Metraipolis › archive › dc_960883b5fb61

Effectiveness of leniolisib in reducing infections among patients with activated phosphoinositide 3-kinase δ syndrome (APDS) — Europe PMC PMID:42925385

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42925385
DOI
10.1007/s12026-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-10-31T20:24:28.486Z
SHA-256 of the archived text
2df54008382051d7d8c024fc5789bbadc77ad3c9e51e98c7bbf004aa3db4dc57
Stable URL of this page
https://metraipolis.com/documento/dc_960883b5fb61

How to cite

Effectiveness of leniolisib in reducing infections among patients with activated phosphoinositide 3-kinase δ syndrome (APDS) — Europe PMC PMID:42925385 — Europe PMC (en), https://europepmc.org/article/MED/42925385 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_960883b5fb61 (Metraipolis archive dc_960883b5fb61, sha256 2df54008382051d7d8c024fc5789bbadc77ad3c9e51e98c7bbf004aa3db4dc57)
BibTeX
@misc{dc960883b5fb61,
  title = {Effectiveness of leniolisib in reducing infections among patients with activated phosphoinositide 3-kinase δ syndrome (APDS) — Europe PMC PMID:42925385},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42925385},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_960883b5fb61; sha256 2df54008382051d7d8c024fc5789bbadc77ad3c9e51e98c7bbf004aa3db4dc57},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42925385. Agents can read the archived copy with the MCP tool read_document.